[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606742":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":20,"responsibleParty":33,"collaborators":35,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Bioceramed","INDUSTRY",null,[9],{"name":10,"affiliation":11,"role":12},"João Botelho","Egas Moniz School of Health and Science Caparica, Lisboa, Portugal","PRINCIPAL_INVESTIGATOR",[14],{"name":15,"role":16,"phone":17,"phoneExt":18,"email":19},"Alexandre Barros","CONTACT","253 573 460","+351","info@bioceramed.com",[21],{"facility":22,"status":23,"city":24,"state":7,"zip":7,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":7},"Egas Moniz School of Health and Science","RECRUITING","Lisbon","Portugal","PT",{"type":28,"coordinates":29},"Point",[30,31],-9.1498,38.72509,{"lat":31,"lon":30},{"type":34,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[36],{"name":37,"class":38},"Egas Moniz - Cooperativa de Ensino Superior, CRL","OTHER","100606742","evaluation-of-the-safety-and-performance-of-the-neocement-inject-p-a-prospective-observational-study-in-dental-area-100606742",false,"NCT07179510","Evaluation of the Safety and Performance of the Neocement® Inject P: A Prospective Observational Study in Dental Area","NeoInjDent01","Inclusion Criteria:\n\n* Adult males or females (age \\> 18 years old);\n* Patients who are able to sign an informed consent form (for data collection);\n* Patients undergoing reconstructive dental surgery and indicated for the use of Neocement® Inject P;\n\nExclusion Criteria:\n\n* Patients who are unable to understand consent and the objectives of the study;\n* Signs of local or systemic acute\u002F active or chronic infections;\n* Metabolic affections;\n* Severe degenerative diseases, conditions in which general bone grafting is not advisable;\n* Implementation sites that allow product migration;\n* Conditions which require structural support in the skeletal system;\n* Conditions where the implantation site is unstable and not rigidly fixated;\n* Sensibility to the implantable materials;\n* Known hypersensitivity to the implant material.","ALL","18 Years",{"count":49,"type":50},66,"ESTIMATED","OBSERVATIONAL","This study aims to collect real-world clinical data to gather information on the performance and safety of the Neocement® Inject P when used according to its intended purpose and current clinical applications. The results of the clinical study will serve as clinical evidence for the device's clinical evaluation.",[54],"Bone Augmentation",[56,57,58,59,60,61,62,63,64,65],"prospective observational clinical study","bone substitute","bone defects","real-world clinical data","safety","performance","medical device","reconstructive dental surgeries","Neocement® Inject P","calcium phosphates","2026-06-17",{"date":68,"type":69},"2026-06-18","ACTUAL",{"date":71,"type":69},"2025-10-06",{"date":73,"type":50},"2027-10",{"name":5,"class":6},1]